Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Long-term Use of Calcium Channel Blockers (CCB) and Risk of Breast Cancer: A Retrospective Longitudinal Observational Study

NCT05972785 is registered in ClinicalTrials.gov with Curtin University as lead sponsor.

NCT NCT05972785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05972785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Long-term Use of Calcium Channel Blockers (CCB) and Risk of Breast Cancer: A Retrospective Longitudinal Observational Study
Lead sponsor
Curtin University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2022
Completion date
December 31, 2025
Enrollment
68,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hypertension,essential